Healthy Living
FDA Approves New Gene Therapy for Sickle Cell Disease Patients
Fifteen-year-old Yasmin Mbeyu at UCLA Health recently became the first pediatric patient to receive a novel gene therapy for sickle cell disease, marking a historic shift from lifelong management to a
Chloe Bennett·September 17, 2026
